Microglial Function in Autism Spectrum Disorder: Diversity, Immunometabolic Processes, and Synaptic Pathways - Scorecard - MDSpire

Microglial Function in Autism Spectrum Disorder: Diversity, Immunometabolic Processes, and Synaptic Pathways

  • By

  • Aojie Lian

  • Mei He

  • Hong Zhang

  • Yingmei Yang

  • April 28, 2026

  • 0 min

Share

Clinical Scorecard: Microglial Function in Autism Spectrum Disorder: Diversity, Immunometabolic Processes, and Synaptic Pathways

At a Glance

CategoryDetail
ConditionAutism Spectrum Disorder (ASD)
Key MechanismsMicroglial heterogeneity, immunometabolic regulation, synapse-related pathways
Target PopulationIndividuals with Autism Spectrum Disorder
Care SettingNeuroscience and psychiatric research

Key Highlights

  • Microglial biology in ASD is heterogeneous and context-dependent.
  • Evidence suggests immune- and glia-associated alterations in ASD brains.
  • Microglia interact with neurons and astrocytes, influencing synaptic remodeling.
  • Current findings challenge the notion of a single ASD microglial phenotype.
  • Immunometabolic processes are critical in understanding microglial function in ASD.

Guideline-Based Recommendations

Diagnosis

  • Consider the role of microglial biology in ASD diagnosis.

Management

  • Focus on context-dependent microglial responses rather than broad inflammatory labels.

Monitoring & Follow-up

  • Utilize in vivo neuroimmune imaging to assess glial activity.

Risks

  • Be aware of confounding factors such as developmental stage and comorbidities.

Patient & Prescribing Data

Individuals diagnosed with Autism Spectrum Disorder

Understanding microglial function may inform therapeutic strategies.

Clinical Best Practices

  • Integrate findings from multiple neural and glial compartments in ASD research.
  • Avoid oversimplifying microglial responses to non-specific inflammatory terms.
  • Consider developmental timing and cellular context in interpreting microglial data.

References

Original Source(s)

Related Content